TY - JOUR
T1 - Capacity for the management of kidney failure in the International Society of Nephrology Middle East region
T2 - Report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
AU - Karam, Sabine
AU - Amouzegar, Atefeh
AU - Rashed Alshamsi, Iman
AU - M.G. Al Ghamdi, Saeed
AU - Caskey, Fergus J
AU - Savaj, Shokoufeh
AU - al, et
N1 - Publisher Copyright:
© 2024 International Society of Nephrology
PY - 2024/4/8
Y1 - 2024/4/8
N2 - The highest financial and symptom burdens and the lowest health-related quality of life scores are seen in people with kidney failure. A total of 11 countries in the International Society of Nephrology (ISN) Middle East region responded to the ISN-Global Kidney Health Atlas. The prevalence of chronic kidney disease (CKD) in the region ranged from 4.9% in Yemen to 12.2% in Lebanon, whereas prevalence of kidney failure treated with dialysis or transplantation ranged from 152 per million population (pmp) in the United Ara Emirates to 869 pmp in Kuwait. Overall, the incidence of kidney transplantation was highest in Saudi Arabia (20.2 pmp) and lowest in Oman (2.2 pmp). Chronic hemodialysis (HD) and peritoneal dialysis (PD) services were available in all countries while kidney transplantation was available in most countries of the region. Public government funding that makes acute dialysis, chronic HD, chronic PD, and kidney transplantation medications free at the point of delivery was available in 54.5%, 72.7%, 54.5%, and 54.5% of countries, respectively. Conservative kidney management was available in 45% of countries. Only Oman had a CKD registry while 7 (64 %) countries had dialysis registries and 8 (73%) had kidney transplantation registries. The ISN Middle East region has a high burden of kidney disease and multiple challenges to overcome. Prevention and detection of kidney disease can be improved by the design of tailored guidelines, allocating additional resources, improving early detection at all levels of care, and implementing sustainable health information systems.
AB - The highest financial and symptom burdens and the lowest health-related quality of life scores are seen in people with kidney failure. A total of 11 countries in the International Society of Nephrology (ISN) Middle East region responded to the ISN-Global Kidney Health Atlas. The prevalence of chronic kidney disease (CKD) in the region ranged from 4.9% in Yemen to 12.2% in Lebanon, whereas prevalence of kidney failure treated with dialysis or transplantation ranged from 152 per million population (pmp) in the United Ara Emirates to 869 pmp in Kuwait. Overall, the incidence of kidney transplantation was highest in Saudi Arabia (20.2 pmp) and lowest in Oman (2.2 pmp). Chronic hemodialysis (HD) and peritoneal dialysis (PD) services were available in all countries while kidney transplantation was available in most countries of the region. Public government funding that makes acute dialysis, chronic HD, chronic PD, and kidney transplantation medications free at the point of delivery was available in 54.5%, 72.7%, 54.5%, and 54.5% of countries, respectively. Conservative kidney management was available in 45% of countries. Only Oman had a CKD registry while 7 (64 %) countries had dialysis registries and 8 (73%) had kidney transplantation registries. The ISN Middle East region has a high burden of kidney disease and multiple challenges to overcome. Prevention and detection of kidney disease can be improved by the design of tailored guidelines, allocating additional resources, improving early detection at all levels of care, and implementing sustainable health information systems.
U2 - 10.1016/j.kisu.2024.01.009
DO - 10.1016/j.kisu.2024.01.009
M3 - Article (Academic Journal)
C2 - 38618498
SN - 2157-1716
VL - 13
SP - 57
EP - 70
JO - Kidney International Supplements
JF - Kidney International Supplements
IS - 1
ER -